Mark Bakken
General Partner @ Cultivation Capital
Madison, United States
Mark Bakken is a seed investor at Cultivation Capital in Madison focused on Health Care and Information Technology. Mark Bakken is the Founder and Managing Director of HealthX Ventures. He is also a General Partner at Cultivation Capital. He previously worked at Nordic as a Co-Founder and CEO. Mark Bakken attended the University of Wisconsin-Madison.
- Total investments:
- 24
- Last investment:
- Lead investor:
- 54%
Last updated:
For AI agents: llms.txt
Industries Mark Bakken invests in
Stages Mark Bakken invests in
Countries Mark Bakken invests in
Round sizes
Round size
- Seed
- $300k–$4M
- Series A
- $2M–$27M
Investment Focus
Industry
- Health Care 12 (50%)
- Information Technology 6 (25%)
- Medical 4 (17%)
- Software 4 (17%)
- Hospital 3 (13%)
Stage
- Seed 12 (50%)
- Series A 6 (25%)
- Pre-Seed 1 (4%)
- Series B 1 (4%)
- Funding Round 1 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
KeyCare
|
KeyCare is a virtual care platform powered by Epic that was created to assist forward-thinking health systems in increasing patient access and quality by enhancing the alternatives available for virtual care. | $27.4M / Series A / Mar 03, 2026 | |
Cylerity
|
Cylerity's fintech platform inserts between the clearinghouse and the payor, avoiding the need for providers to make changes to their operations or RCM procedures. The advance is made within hours of submitting the claim, allowing saving programs to be implemented from procurement to debt service. With cylerity, commercial insurance claims andmedicare reimbursements can be processed rapidly. | $4M / Seed / Oct 28, 2025 | |
WPS
|
WPS, a health solutions company, is an independent, not-for-profit, local partner based in Madison, Wisconsin. We’ve provided health insurance and benefit plan administration to millions of private and government members for almost 80 years. To us, it’s about more than delivering trusted and unparalleled expertise in the most demanding ofbusinesses. It’s also about caring for those we serve—and exploring new and innovative ways to bring value to their lives. | Venture - Series Unknown / Oct 20, 2025 | |
|
Brooklyn Health
|
Brooklyn Health is a company of clinicians, scientists, and engineers dedicated to enhancing digital health measurement. | $6.5M / Seed / May 27, 2025 | |
Amulet
|
Amulet is shining a light on invisible threats in our food system. Amulet has two core brands: - Allergy Amulet helps consumers determine whether their foods are safe by detecting potentially life-threatening allergenic ingredients. - Amulet Scientific equips businesses and manufacturers with tools to help ensure the safety of their food supplychain. Learn more: www.allergyamulet.com www.amuletscientific.com | $5.8M / Series A / Aug 12, 2024 | |
Amulet
|
Allergy Amulet is the world’s smallest and fastest consumer food allergen sensor, testing for common allergenic ingredients in seconds. Whether it’s on a keychain, a necklace, a wristband, or in a pocket, Allergy Amulet’s sleek and portable design allows users to savor life’s important moments, safely and simply. Food allergies affect 32 millionAmericans and between 220-520 million people globally. That’s 1 in 13 children and 1 in 10 adults. Allergy Amulet has the potential to improve the quality of life for the millions of people living with food allergies or intolerances. | $5.8M / Series A / Aug 12, 2024 | |
RxLightning
|
RxLightning is a digital solution for specialty medication access, accelerating patients’ speed to therapy. | $17.5M / Series A / Jun 06, 2023 | |
CancerIQ
|
CancerIQ provides a precision prevention platform that empowers healthcare providers to engage patients, stratify risk and ensure adherence with the latest evidence-based strategies to get ahead of cancer. It offers a robust content library of evidence-based guidelines and risk models to help providers interpret data and navigate patients to theappropriate genetic testing, screening, or treatment interventions. | $14M / Series B / Mar 03, 2022 | |
Ideawake
|
Ideawake provides an easy to use innovation platform combined with programs, services, and expertise that supports the innovation program. Its SaaS idea management platform enables employers to (1) solicit and crowdsource ideas of employees, customers, and vendors to reduce costs, generate additional revenue and engage employees, (2) evaluate andselect the best ideas, and (3) manage the implementation of those ideas. It aims to empower brands with the tools, processes, and connections they need to transform employees into innovators and their ideas into measurable impact.Ideawake was founded in 2013 and is headquartered in Milwaukee, Wisconsin. | $1M / Seed / Feb 03, 2022 | |
Nurse Disrupted
|
Nurse Disrupted solves complex health problems through simple solutions. | $700K / Seed / Nov 24, 2021 | |
| See all 24 investments → | |||
Co-Investors
Everywhere Ventures
4 deals together
Great Oaks Venture Capital
3 deals together
CSA Partners LLC
2 deals together
Incite.org
2 deals together
LRVHealth
2 deals together
About Cultivation Capital
Cultivation Capital is a venture capital firm that manages a family of funds focused on early-stage investing. Most of our initial investments are during a startup’s Seed or Series A phase, and our initial checks range from $500k – $3.5M. Our industries of focus include life sciences and health tech, software and IT, agriculture tech, andgeospatial tech.
Cultivation Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alana Mann
Principal
|
|||
Andy Dearing
General Partner
|
|||
Brian Matthews
Co-Founder & General Partner
|
|||
David Smoller
General Partner - Life Sciences Fund
|
|||
Dean VandeKamp
General Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Mark Bakken invest in?
Mark Bakken invests primarily in Health Care, Information Technology and Medical startups, most often at Seed and Series A stage. Most of the 24 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Mark Bakken's check size?
Mark Bakken typically joins rounds of $300k–$4M at Seed and $2M–$27M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Mark Bakken participates in.
When did Mark Bakken last invest?
The most recent investment recorded for Mark Bakken closed in Mar 2026. Shizune tracks 24 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
